Literature DB >> 21438907

MELF invasion in endometrial cancer as a risk factor for lymph node metastasis.

Kitty Pavlakis1, Irini Messini, Thomas Vrekoussis, Theodoros Panoskaltsis, Dimitris Chrysanthakis, Petros Yiannou, Zannis Voulgaris.   

Abstract

AIM: To investigate whether the microcystic, elongated and fragmented (MELF) pattern of myometrial invasion encountered in certain endometrioid endometrial carcinomas can be considered as a risk factor for lymph node metastasis. METHODS AND
RESULTS: A total of 351 cases of total abdominal hysterectomy and bilateral salpingo-oophorectomy with/without lymphadenectomy or lymph node sampling, performed for endometrioid endometrial adenocarcinoma, were included in this study. The existence of MELF invasion, vascular invasion, fibromyxoid stromal reaction and lymph node metastasis were recorded. Immunohistochemistry for endothelial and epithelial markers was performed on selected cases. MELF invasion was identified in 20 (10.81%) and 13 cases (13.13%) treated without and with lymphadenectomy, respectively. All these cases were either well or moderately differentiated carcinomas, stages IA-II (without considering lymph node status). Positive lymph nodes were detected in seven of 13 MELF-positive (53.84%) and six of 86 MELF-negative cases (6.97%) This observation was statistically significant. Of the seven MELF-positive tumours with lymph node metastasis, three cases exhibited intravascular tumour emboli while four showed a fibromyxoid stromal reaction.
CONCLUSION: MELF pattern invasion was found to be related statistically to lymph node metastasis. Nevertheless, further studies are needed in order to evaluate the clinical significance of this observation.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Year:  2011        PMID: 21438907     DOI: 10.1111/j.1365-2559.2011.03802.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  17 in total

1.  Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.

Authors:  Stefan Kommoss; Andreas D Hartkopf; Bernhard Krämer; Anne-Kathrin Bunz; Friederike Grevenkamp; Felix Kommoss; Jana Pasternak; Sabine M Arbabi; Markus Wallwiener; Annette Staebler; Sigurd F Lax; Sara Y Brucker; Florin-Andrei Taran
Journal:  J Cancer Res Clin Oncol       Date:  2017-07-14       Impact factor: 4.553

2.  The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcinomas.

Authors:  Amy S Joehlin-Price; Kelsey E McHugh; Julie A Stephens; Zaibo Li; Floor J Backes; David E Cohn; David W Cohen; Adrian A Suarez
Journal:  Am J Surg Pathol       Date:  2017-01       Impact factor: 6.394

Review 3.  Practical issues related to uterine pathology: staging, frozen section, artifacts, and Lynch syndrome.

Authors:  Robert A Soslow
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

Review 4.  How to approach the many faces of endometrioid carcinoma.

Authors:  Anais Malpica
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

5.  Infiltration pattern predicts metastasis and progression better than the T-stage and grade in pancreatic neuroendocrine tumors: a proposal for a novel infiltration-based morphologic grading.

Authors:  Orhun Cig Taskin; Michelle D Reid; Pelin Bagci; Serdar Balci; Ayse Armutlu; Deniz Demirtas; Burcin Pehlivanoglu; Burcu Saka; Bahar Memis; Emine Bozkurtlar; Can Berk Leblebici; Adelina Birceanu; Yue Xue; Mert Erkan; Yersu Kapran; Arzu Baygul; Cenk Sokmensuer; Aldo Scarpa; Claudio Luchini; Olca Basturk; Volkan Adsay
Journal:  Mod Pathol       Date:  2021-12-30       Impact factor: 7.842

6.  The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma.

Authors:  Elizabeth Euscher; Patricia Fox; Roland Bassett; Hayma Al-Ghawi; Rouba Ali-Fehmi; Denise Barbuto; Bojana Djordjevic; Elizabeth Frauenhoffer; Insun Kim; Sun Rang Hong; Delia Montiel; Elizabeth Moschiano; Andres Roma; Elvio Silva; Anais Malpica
Journal:  Am J Surg Pathol       Date:  2013-11       Impact factor: 6.394

7.  Clinicopathologic Association and Prognostic Value of MELF Pattern in Invasive Endocervical Adenocarcinoma (ECA) as Classified by IECC.

Authors:  Sheila E Segura; Lien Hoang; Monica Boros; Cristina Terinte; Anna Pesci; Sarit Aviel-Ronen; Takako Kiyokawa; Isabel Alvarado-Cabrero; Esther Oliva; Kay J Park; Robert A Soslow; Simona Stolnicu
Journal:  Int J Gynecol Pathol       Date:  2020-09       Impact factor: 3.326

8.  S100A4 accelerates the proliferation and invasion of endometrioid carcinoma and is associated with the "MELF" pattern.

Authors:  Shinichiro Tahara; Satoshi Nojima; Kenji Ohshima; Yumiko Hori; Masako Kurashige; Naoki Wada; Jun-Ichiro Ikeda; Eiichi Morii
Journal:  Cancer Sci       Date:  2016-08-12       Impact factor: 6.716

9.  Microcystic, elongated, and fragmented pattern of invasion in relation to histopathologic and clinical prognostic factors in endometrioid endometrial adenocarcinoma.

Authors:  M Murat Naki; Gülbin Oran; Seza Ümit Tetikkurt; Cavide Fatma Sönmez; İlknur Türkmen; Faruk Köse
Journal:  J Turk Ger Gynecol Assoc       Date:  2017-09-01

10.  Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?

Authors:  Menghan Zhu; Nan Jia; Feifei Huang; Xiaoxia Liu; Yuqing Zhao; Xiang Tao; Wei Jiang; Qin Li; Weiwei Feng
Journal:  BMC Cancer       Date:  2017-10-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.